- Home
- TNET vs VKTX Comparison
TNET vs VKTX Comparison
Compare TNET & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNET | VKTX |
|---|---|---|
| Founded | 1988 | 2012 |
| Country | United States | United States |
| Employees | 2700 | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TNET | VKTX |
|---|---|---|
| Price | $66.03 | $29.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 21 |
| Target Price | $66.20 | ★ $95.32 |
| AVG Volume (30 Days) | 333.2K | ★ 4.0M |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.70 | N/A |
| Revenue | ★ $5,010,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.82 | N/A |
| P/E Ratio | $17.60 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.67 | $23.82 |
| 52 Week High | $76.59 | $43.10 |
Technical Indicators
Market Signals| Indicator | TNET | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 54.23 |
| Support Level | $64.84 | $28.77 |
| Resistance Level | $71.56 | $34.29 |
| Average True Range (ATR) | 3.54 | 1.82 |
| MACD | -0.39 | 0.49 |
| Stochastic Oscillator | 38.51 | 82.01 |
Price Performance
Historical ComparisonAbout TNET TriNet Group Inc.
Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.